COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Comparing the Use of Saline or Saline Plus Gentamycin in Nasal Irrigation to Treat Chronic Sinusitis in Children

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00465530
Recruitment Status : Completed
First Posted : April 25, 2007
Results First Posted : May 29, 2013
Last Update Posted : May 29, 2013
Information provided by (Responsible Party):
Julie Wei, MD, University of Kansas Medical Center

Brief Summary:
Healthy children may develop symptoms of chronic sinusitis such as chronic cough, chronic runny nose, nasal congestion, even headaches. Such symptoms may persist long after the child gets over other symptoms of a cold and commonly result in the prescription of oral antibiotics. The purpose of this study is to evaluate whether using saline alone or saline plus an antibiotic (gentamycin) to irrigate the nose directly once a day for 6 weeks is effective and safe for the treatment of the above named symptoms. Computerized axial tomography (CAT) scans and quality of life surveys will be used to compare the health of the sinuses before and after treatment, and scored to determine which of the two treatments, saline alone or saline with gentamycin, is more effective in the treatment of this condition. The study hypothesis is that intranasal saline irrigation will work as well as saline plus gentamycin, and that majority of the patients will experience significant improvement after a 6 week treatment period.

Condition or disease Intervention/treatment Phase
Sinusitis Drug: Saline Drug: Gentamycin Not Applicable

Detailed Description:

In the pediatric population, rhinosinusitis is a common concern resulting frequently in the frequent and unsuccessful prescription of systemic oral antibiotic therapy. Children typically experience an estimated 6-8 upper respiratory illnesses per year, usually viral, and only 13% are estimated to result in true sinusitis. True and chronic sinusitis, if not adequately treated, may result in long term symptoms including nasal airway obstruction, nasal congestion, persistent mucopurulent rhinorrhea, daytime and nocturnal cough, headaches, daytime fatigue, and even exacerbation or poor control of underlying asthma. A child's quality of life can be severely impacted as is their caretaker's due to days of missed school, frequency of doctor visits and courses of oral antibiotic therapy prescribed for the above mentioned symptoms, which ultimately result in the development of resistant organisms in addition to potential negative side effects associated with systemic oral antibiotic use.

Intranasal saline irrigation is underutilized in the pediatric population, most likely due to the presumption that children will not cooperate nor tolerate the act of irrigation. Saline irrigation of the nose is an inexpensive and generally well tolerated treatment with very little side effects or risks. Rigorous data regarding the efficacy of saline irrigation has become more available in this past decade, with most studies demonstrating a clear improvement in patient quality of life as measured by various study instruments or outcome surveys.

In our protocol, patients will be randomized to receive either saline alone or saline plus gentamycin in the solution form for nasal irrigation once daily for a six week treatment period. Weekly phone calls will be made to check for possible adverse events while patients are on treatment, and at the end of the treatment period another CAT scan will be performed to assess the status of the sinuses. Overall improvement will be determined based on the sinus status on the second CAT scan as well as the quality of life survey filled out by parents.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Safety and Efficacy of Once Daily Intranasal Gentamycin Irrigation Versus Saline in the Treatment of Pediatric Chronic Sinusitis
Study Start Date : March 2007
Actual Primary Completion Date : March 2010
Actual Study Completion Date : March 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sinusitis

Arm Intervention/treatment
Experimental: 2
Saline plus Gentamycin
Drug: Saline
Intranasal Saline

Drug: Gentamycin
Intranasal irrigation

Placebo Comparator: 1
Drug: Saline
Intranasal Saline

Primary Outcome Measures :
  1. Change in Computed Tomography (CT) Score After Treatment [ Time Frame: Change from Baseline to 6 Weeks ]
    Change in CT score reflects the Lund-Mackay staging system. Each sinus is scored separately and scores are determined for the right and the left side. The lowest score of 0 represents no opacification in the sinus. A score of 1 represents a partial opacification. A score of 2 represents complete opacification.

  2. Change in Overall Quality of Life [ Time Frame: 3 Weeks to Follow-Up (7 Weeks) ]
    Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.

Secondary Outcome Measures :
  1. Change in Overall Quality of Life [ Time Frame: Baseline to 3 Weeks ]
    Measured by Quality of Life Survey (SN-5). Scores ranged from 0 - 7. The higher the numerical score, the worse the problem.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   4 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Healthy children age 4-17
  • History of "Recurrent" or "Chronic Sinusitis"

    • Definition: History must include > 3 months of any or a combination of the following symptoms:
    • Nasal congestion/nasal airway obstruction
    • Rhinorrhea/Nasal discharge
    • Persistent cough (daytime)
    • Postnasal drip
    • Headache
    • Facial pain
    • Foul breath
    • Intermittent fever
  • Caregiver (proxy responsible) able to read and understand English
  • Has had at least 3 courses or a total of 21 days of oral antibiotic therapy for above symptoms in the previous 3 months
  • Child has a CT scan of the coronal sinus without contrast within two months prior to visit date, which demonstrates and opacification of a single or multiple, ipsilateral or bilateral sinuses.

Exclusion Criteria:

  • Inability of caregiver to read and understand English
  • Mental retardation, cognitive impairment, or developmental delay
  • History of cystic fibrosis
  • History of immotile cilia syndrome
  • History of immune suppression/immune compromise
  • CT scan within past 4 weeks available for review at time of clinic visit which is entirely negative for evidence of sinus disease plus complete absence of any of the above symptoms
  • History of endoscopic sinus surgery
  • History of patient's inability to tolerate attempted nasal irrigation in the past 6 months
  • History of recent use of gentamycin intranasal irrigation or saline irrigation within the past 3 months
  • History of presence of nasal polyposis
  • History of allergic reaction of any kind to intravenous gentamycin or aminoglycosides in past medical history (for treatment of any infections)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00465530

Layout table for location information
United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
University of Kansas MedWest
Shawnee, Kansas, United States, 66217
Sponsors and Collaborators
Julie Wei, MD
Layout table for investigator information
Principal Investigator: Julie L Wei, M.D. University of Kansas Medical Center
Layout table for additonal information
Responsible Party: Julie Wei, MD, Associate Professor, University of Kansas Medical Center Identifier: NCT00465530    
Other Study ID Numbers: 10553
First Posted: April 25, 2007    Key Record Dates
Results First Posted: May 29, 2013
Last Update Posted: May 29, 2013
Last Verified: April 2013
Additional relevant MeSH terms:
Layout table for MeSH terms
Paranasal Sinus Diseases
Nose Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Otorhinolaryngologic Diseases
Anti-Bacterial Agents
Anti-Infective Agents
Protein Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action